Keywords: genentech, withdraws, raptiva, market, due, fatal, cases

Genentech withdraws Raptiva from US market due to fatal cases of PML

Article | 09 April 2009

Print This

US biotechnology firm Genentech, full control of which has now been acquired by Swiss drug giant Roche, has begun a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in